Skip to main content

Advertisement

Log in

Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer

  • Letter to the editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bartsch R, Rottenfusser A, Wenzel C et al (2007) Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer. J Neurooncol Jun 8 [Epub ahead of print]

  2. van Vulpen M, Kal HB, Taphoorn MJ, El-Sharouni SY (2002) Changes in blood–brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review). Oncol Rep 9:683–688

    PubMed  Google Scholar 

  3. Liang K, Lu Y, Jin W et al (2003) Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther 2:1113–1120

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kadri Altundag.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bulut, N., Harputluoglu, H., Dizdar, O. et al. Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer. J Neurooncol 86, 241 (2008). https://doi.org/10.1007/s11060-007-9447-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-007-9447-7

Keywords

Navigation